When was Roam founded?

Roam was founded in 2013 and raised its 1st funding round within a year of its incorporation.

Where is Roam located?

Roam is headquartered in San Mateo, United States. It is registered at San Mateo, California.

How many employees does Roam have?

As of Aug 31, 2026, the latest employee count at Roam is 3.

Is Roam a funded company?

Roam is a funded company, having raised a total of $22.4M across 4 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Nov 20, 2013.

When was the latest funding round of Roam?

Roam's latest funding was a $***** Series B round on May 03, 2016, with participation from 1 investor. Its primary sector is Life Sciences Tech. In United States, the Life Sciences Tech sector has seen $3.47B in funding in 2026 to date.

Where does Roam rank among its competitors?

Roam ranks 9th amongst 126 active competitors, of which 30 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was Sinopia Biosciences, which secured $2.82M in Jun, 2026.

Who are the top competitors of Roam?

Roam's top competitors include Dandelion Health, Genedata and OccamzRazor. Among them, Sinopia Biosciences secured the most recent funding round in June, 2026.

Roam - 2026 Company Profile, Team, Funding & Competitors

Roam is a series B company based in San Mateo (United States), founded in 2013 by Andrew Maas, Alex Turkeltaub and Andrew Maas. It operates as a Machine learning platform for health data analysis. Roam has raised $22.4M in funding. The company has 126 active competitors, including 30 funded and 10 that have exited. Its top competitors include companies like Dandelion Health, Genedata and OccamzRazor.

Company Details

Roam provides a machine learning platform for analyzing patient and provider pathway analysis. The platform uses comprehensive contextual data to assist biopharmaceutical and medical device companies with the predictive insights they need to make informed decisions as well as provides information on effective treatments. Its platform uses Real-World Evidence (RWE) to inform clinical development, patient outcomes, and risk-sharing agreements. Claims that it helps life sciences companies planning for a new product launch or working to improve the performance of an in-market treatment. Also, provides Roam Health Knowledge Graph for a unified mapping of internal company data, hospital data, and relevant external data to facilitate patient-level insights and drive improvements in care.

Website: www.roamanalytics.com
Social
Registered Address: San Mateo, California

Key Metrics

Founded Year

2013

Location

San Mateo, United States

Stage

Series B

Total Funding

$22.4M in 4 rounds

Latest Funding Round

Series B, May 03, 2016, $*****

Investors

StartX & 8 more

Ranked

9^th among 126 active competitors

Employee Count

3 as on Aug 31, 2026

Similar Companies

OpenEvidence & 3000 more

View Roam's full profile

Roam is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
ROAM ANALYTICS, INC. CIN: 455364192 , United States, Active	May 17, 2012	-	26 (As on Dec 31, 2019)	-

Roam has raised a total funding of $22.4M over 4 rounds. Its first funding round was on Nov 20, 2013. Its latest funding round was a Series B round on May 03, 2016 for $*****. 1 investor participated in its latest round. Roam has 9 institutional investors.

Here is the list of recent funding rounds of Roam:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 03, 2016	7727563	Series B	5319955	6763763	7176677	5171812
Jul 01, 2015	2940583	Series A	2533472	6093714	3077901	Blumberg Capital & 3 more
Dec 18, 2013	5983783	Seed	4057762	3939271	2937426	9951109

Access funding benchmarks and valuations. Sign up today!

View details of Roam's funding rounds and investors

The founders of Roam are Andrew Maas, Alex Turkeltaub and Andrew Maas.

Here are the details of Roam's key team members:

Andrew Maas: Co-Founder of Roam.
Alex Turkeltaub: Former Co-Founder& Chief Executive Officer of Roam.
Andrew Maas: Co-Founder of Roam.

View details of Roam's Founder profiles and Board Members

Roam's employee count trend

Roam has 3 employees as of Aug 26. Here is Roam's employee count trend over the years:

Uncover Roam's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Roam include Dandelion Health, Genedata and OccamzRazor. Here is the list of Top 10 competitors of Roam, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Dandelion Health 2020, New York City (United States), Series A	Provider of AI-powered real-world data platform for clinical development	$29.9M	Primary Venture Partner, Healthier Capital ... & 6 others	61/100
2nd	Genedata 1997, Basel (Switzerland), Acquired	Software solutions for drug discovery, industrial biotechnology, and life science research	-	Novartis Venture Fund, Alta Partners & 1 others	56/100
3rd	OccamzRazor 2015, San Francisco (United States), Series A	Platform to organize and analyze life science information to derive actionable insights	$6.1M	Daybreak Partners, Human Capital & 13 others	56/100
4th	Sinopia Biosciences 2014, San Diego (United States), Seed	Data-driven drug discovery using multi-omics, AI, and disease models	$2.82M	National Cancer Institute, JLABS & 5 others	52/100
5th	Century Health 2023, Santa Monica (United States), Seed	AI-powered health tech company accelerating access to breakthrough treatments	$7M	Origin Ventures, 2048 Ventures & 9 others	51/100
6th	Syntekabio 2009, Sunnyvale (United States), Public	AI-driven drug discovery and development, SaaS platform, supercomputing center	$11.1M	Yozma Group Korea, Altos Ventures Management ... & 5 others	50/100
7th	Perthera 2012, Mclean (United States), Series A	Personalized molecular cancer profiling through genomics and proteomics	$17.8M	Pilot Growth Equity, Invictus Growth	47/100
8th	NashBio 2018, Nashville (United States), Unfunded	Provider of multimodal dataset for drug development	-	-	44/100
9th	Roam 2013, San Mateo (United States), Series B	Machine learning platform for health data analysis	$22.4M	StartX, LDV Partners & 7 others	43/100
10th	Ontoforce 2011, Ghent (Belgium), Series B	Provider of semantic search platform for pharmaceutical and biotech research	$12.7M	Korys, SoFi & 8 others	43/100